Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11107953 | 0.82 | MEN1 (0.52) | ALDH1A1KDM4ESMN1; SMN2MEN1NPC1 | |
| SCHEMBL11103862 | 0.82 | MEN1 (0.52) | ALDH1A1KDM4ESMN1; SMN2MEN1NPC1 | |
| SCHEMBL5487957 | 0.82 | MEN1 (0.52) | ALDH1A1KDM4ESMN1; SMN2MEN1NPC1 | |
| Hydrochloric Acid SCHEMBL28371398 | 0.79 | MEN1 (0.50) | ALDH1A1SMN1; SMN2MEN1NPC1HSP90AA1 | |
| Benzene SCHEMBL28173940 | 0.77 | MEN1 (0.48) | ALDH1A1TSHRSMN1; SMN2MEN1NPC1 | |
| SCHEMBL672540 | 0.76 | — | — | |
| Propane SCHEMBL28437167 | 0.76 | MEN1 (0.44) | ALDH1A1SMN1; SMN2MEN1NPC1HSP90AA1 | |
| SCHEMBL5174649 | 0.72 | NPC1 (0.54) | ALDH1A1LMNAKDM4ETSHRSMN1; SMN2 | |
| SCHEMBL18087701 | 0.72 | NPC1 (0.54) | ALDH1A1LMNAKDM4ETSHRSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL5711645 | 0.71 | NPC1 (0.53) | ALDH1A1LMNAKDM4ETSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296984-A1 | THERAPEUTIC AND DIAGNOSTIC AGENTS AND USES THEREOF | THELPER AS (NO) | 2025-09-25 | — | — | US | disclosed |
| US-20140065148-A1 | TREATMENT METHODS USING ANTIBODIES TO AMINOPHOSPHOLIPIDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-03-06 | — | — | US | disclosed |
| US-8501243-B2 | Targeting cancer therapy combination | YU, BAOFA | 2013-08-06 | — | — | US | disclosed |
| US-20120214757-A1 | Methods and Compositions for Treating Cancer Using Proteasome Inhibitors | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2012-08-23 | — | — | US | disclosed |
| US-20120064037-A1 | Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2012-03-15 | — | — | US | disclosed |
| US-7871775-B2 | Compositions and methods for the identification, assessment, prevention and therapy of human cancers | MILLENNIUM PHARMACEUTICALS, INC (US) | 2011-01-18 | — | — | US | disclosed |
| US-20100104660-A1 | COMPOSITION AND METHOD FOR TREATING TUMOR | YU, BAOFA | 2010-04-29 | — | — | US | disclosed |
| US-20080286780-A1 | Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2008-11-20 | — | — | US | disclosed |
| EP-1786411-A2 | 3-HALO-2-OXOPROPIONATE SALTS AND ESTERS AS NOVEL ANTICANCER AGENTS | Board of Regents, The University of Texas System (US) | 2007-05-23 | — | — | EP | disclosed |
| WO-2006020403-A2 | 3-HALO-2-OXOPROPIONATE SALTS AND ESTERS AS NOVEL ANTICANCER AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-02-23 | — | — | WO | disclosed |
| US-6689398-B2 | CONTROLLING APOPTOSIS; ANTITUMOR AGENT; GLYCYRRHETINIC ACID MIXTURES | RESEARCH DEVELOPMENT FOUNDATION | 2004-02-10 | — | — | US | disclosed |
| US-6284267-B1 | Amphiphilic materials and liposome formulations thereof | NUTRIMED BIOTECH | 2001-09-04 | — | — | US | disclosed |
| US-6255347-B1 | ALZHEIMER'S DISEASE | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE | 2001-07-03 | — | — | US | disclosed |
| WO-1997048391-A9 | METHODS AND COMPOSITIONS COMPRISING R-IBUPROFEN | — | 1998-04-09 | — | — | WO | disclosed |
| WO-1997048391-A2 | METHODS AND COMPOSITIONS COMPRISING R-IBUPROFEN | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE (US) | 1997-12-24 | — | — | WO | disclosed |
| EP-0667778-A1 | TREATMENT OF MELANOMA WITH ANTISENSE OLIGONUCLEOTIDES TO C-MYB PROTO-ONCOGENE | Temple University of the Commonwealth System of Higher Education (US) | 1995-08-23 | — | — | EP | disclosed |
| WO-1993009789-A1 | TREATMENT OF MELANOMA WITH ANTISENSE OLIGONUCLEOTIDES TO C-MYB PROTO-ONCOGENE | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1993-05-27 | — | — | WO | disclosed |